recombinant mouse il 21 protein (Sino Biological)
95
Structured Review
Sino Biological
recombinant mouse il 21 protein
Recombinant Mouse Il 21 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+il+21+protein/Mouse+Interleukin-2+IL-2+Protein/pmc12506828-387-47-51
Average 95 stars, based on 36 article reviews
Recombinant Mouse Il 21 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+il+21+protein/Mouse+Interleukin-2+IL-2+Protein/pmc12506828-387-47-51
Average 95 stars, based on 36 article reviews
recombinant mouse il 21 protein - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
In Vivo:Article Title: Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity Article Snippet: For the in vivo blocking of CD40L, antibodies were administered intraperitoneally at 200 μg antibody/mouse on days 1, 3, 5, 7, 9, 11 after ACT compared to their respective isotype control (αCD40L, clone MR-1, with polyclonal Armenian hamster IgG, BioXCell). .. For the in vivo administration of CD40 and IL-21, 100 μg/mouse of CD40 agonist was administered intraperitoneally on day 8 post irradiation and 20 μg/mouse of IL-21 was administered intraperitoneally on days 8, 9, 10, 11, and 12 post irradiation, as previously published (αCD40, clone FGK4.5/FGK45, BioXCell; Irradiation:Article Title: Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity Article Snippet: For the in vivo blocking of CD40L, antibodies were administered intraperitoneally at 200 μg antibody/mouse on days 1, 3, 5, 7, 9, 11 after ACT compared to their respective isotype control (αCD40L, clone MR-1, with polyclonal Armenian hamster IgG, BioXCell). .. For the in vivo administration of CD40 and IL-21, 100 μg/mouse of CD40 agonist was administered intraperitoneally on day 8 post irradiation and 20 μg/mouse of IL-21 was administered intraperitoneally on days 8, 9, 10, 11, and 12 post irradiation, as previously published (αCD40, clone FGK4.5/FGK45, BioXCell; Recombinant:Article Title: Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity Article Snippet: For the in vivo blocking of CD40L, antibodies were administered intraperitoneally at 200 μg antibody/mouse on days 1, 3, 5, 7, 9, 11 after ACT compared to their respective isotype control (αCD40L, clone MR-1, with polyclonal Armenian hamster IgG, BioXCell). .. For the in vivo administration of CD40 and IL-21, 100 μg/mouse of CD40 agonist was administered intraperitoneally on day 8 post irradiation and 20 μg/mouse of IL-21 was administered intraperitoneally on days 8, 9, 10, 11, and 12 post irradiation, as previously published (αCD40, clone FGK4.5/FGK45, BioXCell; |